EcoDrugPlus

Phosphodiesterase 10a

Ensembl ID : ENSOKIG00005038689
Gene Symbol: PDE10A
3 Cross references
200 Possible Orthologues:

Phosphodiesterase 10a

Ensembl ID : ENSOKIG00005044538
Gene Symbol: PDE10A
1 Cross references
200 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSOKIG00005016625
Gene Symbol: PDE3A
1 Cross references
209 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSOKIG00005030647
Gene Symbol: PDE3A
1 Cross references
198 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSOKIG00005024788
Gene Symbol: PDE3A
3 Cross references
207 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSOKIG00005014164
Gene Symbol: PDE3B
1 Cross references
209 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSOKIG00005004875
Gene Symbol: PDE3B
3 Cross references
210 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSOKIG00005028970
Gene Symbol: PDE4A
3 Cross references
197 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSOKIG00005028072
Gene Symbol: PDE4A
1 Cross references
196 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOKIG00005013669
Gene Symbol: PDE4B
3 Cross references
218 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOKIG00005029281
Gene Symbol: PDE4B
3 Cross references
218 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOKIG00005032897
Gene Symbol: PDE4B
1 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).